Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Science
Vishwam Sankaran

Promising drug found to double survival rate for advanced pancreatic cancer patients

The drug daraxonrasib could be a potential new treatment to double the survival of advanced pancreatic cancer patients, a groundbreaking new clinical trial suggests.

Pancreatic cancer patients often discover the disease after it has already spread and cannot be surgically removed.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.